Houlihan Financial Resource Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,700	Closed	-$591K	–	98
2023 Q2	$591K	Buy	+21,700	New	+$591K	0.02%	104
2020 Q3	$17K	Buy	+350	New	+$17K	0.01%	242